Cargando…

Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis

PURPOSE: Bladder cancer is one of the leading causes of cancer death all over the world, and half of patients are diagnosed at advanced stages with poor therapeutic response. Thus, developing new biomarkers for bladder cancer diagnosis and prognosis is urgently needed. MATERIALS AND METHODS: Bioinfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chen, Liu, Xiaoping, Jiang, Jiazhi, Li, Shenjuan, Wang, Gang, Ju, Lingao, Wang, Fubing, Liu, Tongzu, Li, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494396/ https://www.ncbi.nlm.nih.gov/pubmed/32982295 http://dx.doi.org/10.2147/OTT.S243452

Ejemplares similares

To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer
por: Jiang, Jiazhi, et al.
Publicado: (2020)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

DNA Methylation-Based Panel Predicts Survival of Patients With Clear Cell Renal Cell Carcinoma and Its Correlations With Genomic Metrics and Tumor Immune Cell Infiltration
por: Liu, Xiao-Ping, et al.
Publicado: (2020)

Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways
por: Deng, Zhao, et al.
Publicado: (2023)

Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer
por: Li, Sheng, et al.
Publicado: (2017)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
por: El Demery, Mounira, et al.
Publicado: (2014)

Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma
por: Yang, Haoran, et al.
Publicado: (2019)

Matrix Metalloproteinases and Bladder Cancer: What is New?
por: Rodriguez Faba, O., et al.
Publicado: (2012)

ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer
por: Yao, Jie, et al.
Publicado: (2020)

Correction for: ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer
por: Yao, Jie, et al.
Publicado: (2022)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Li, Chien-Chang, et al.
Publicado: (2020)

High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma
por: Liu, Na, et al.
Publicado: (2021)

Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis
por: Liu, Xingkai, et al.
Publicado: (2019)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer
por: Mohammed, Mohammed A, et al.
Publicado: (2013)

Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis
por: Miao, Chenkui, et al.
Publicado: (2017)

Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis
por: Xin, Xing, et al.
Publicado: (2021)

Evaluation of 11 Scoring Functions Performance on Matrix Metalloproteinases
por: Shamsara, Jamal
Publicado: (2014)

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis
por: Wang, Ji, et al.
Publicado: (2017)

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2010)

Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer
por: Luo, Yongwen, et al.
Publicado: (2020)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

BORA regulates cell proliferation and migration in bladder cancer
por: Cheng, Songtao, et al.
Publicado: (2020)

Exogenous Tissue Inhibitor of Metalloproteinase-2 Affects Matrix Metalloproteinase-2 Expression in Conjunctival Filtering Blebs and Bleb Scarring in Rats
por: Wang, Ling, et al.
Publicado: (2018)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
por: Bolenz, Christian, et al.
Publicado: (2018)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer
por: Zhang, Yangyu, et al.
Publicado: (2020)

Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations☆
por: Di, Fei, et al.
Publicado: (2012)

Matrix Metalloproteinases as a Pleiotropic Biomarker in Medicine and Biology
por: Kurzepa, Jacek, et al.
Publicado: (2016)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_e9293o8j0mjqq4r8vnot7s9uij